Spiracin 1.5 MIU
Spiramycine
Category: Tablet
Manufacturer: Drug International Ltd.
Allopathic
MFG. Licence No. Biological
398
MFG. Licence No. Non-Biological
127
Address
Tongi I/A, Gazipur
Medicine Selling service is not available yet.
Related Medicines
Uses of Spiracin:
- Toxoplasmosis during pregnancy
Susceptible infections, Cryptosporidiosis, Toxoplasmosis, Protozoal infections
Hypersensitivity.
How to use
Spiramycine:
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.
Spiramycine is to be taken empty stomach.
Administration:
May be taken with or without food.
Adult Dose:
Oral
Toxoplasmosis; Protozoal infections; Cryptosporidiosis; Susceptible infections
Adult: 6-9 million units/day in 2-3 divided doses, increased to 15 million units/day, given in divided doses for severe infections.
Child Dose:
Oral
Child and Neonates:
Chemoprophylaxis of congenital toxoplasmosis:
50 mg/kg bid.
Decreases carbidopa absorption and levodopa concentrations. Increased risk of ventricular arrhythmias when used with astemizole, cisapride and terfenadine. Risk of acute dystonia when used with fluphenazine.
Hypersensitivity.
Common
- Nausea
- Vomiting
- Abdominal pain
- Diarrhea
- Allergy
Nausea, vomiting, abdominal pain, diarrhoea; urticaria, pruritus, macular rashes. Transient paraesthesia may occur.
Potentially Fatal: Pseudomembranous colitis; anaphylaxis; neuromuscular blockade; ventricular arrhythmias, prolongation of QT interval.
Precaution:
Hepatic impairment; pregnancy and lactation. Monitor liver function. History of arrhythmias or predisposition to QT interval prolongation.
Spiramycin is a macrolide antibacterial that inhibits protein synthesis by irreversibly binding to the 50S subunit of the ribosomal subunit thus blocking the transpeptidation or translocation reactions of susceptible organisms resulting in stunted cell growth
Samm Care